Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

111 drug samples tested in November found ‘not of standard quality’

by AIP Online Bureau | Dec 28, 2024 | Health, Regulation, Risk Management | 0 comments

Besides, 70 drug samples tested by the state drugs testing laboratories have also been identified as NSQ in November, they official sources said

New Delhi: Central Drugs Standard Control Organisation (CDSCO) has found 41 drug samples tested in the central drug laboratories in November as ‘not of standard quality’ (NSQ), official sources said.

Besides, 70 drug samples tested by the state drugs testing laboratories have also been identified as NSQ in November, they said.

Identification of drug samples as NSQ is done based on failure of the drug sample in one or the other specified quality parameters.

“The failure is specific to the drug products of the batch tested by the government laboratory and it does not warrant any concerns on the other drug products available in the market,” an official said.

Two drug samples were identified as spurious drugs in November. Out of the two samples, one was picked by Bihar Drugs Control Authority and the other by CDSCO, Ghaziabad, the sources said.

The drugs were made by unauthorised and unknown manufacturers, using brand names of other companies.

Action to identify NSQ and spurious medicines is taken regularly in collaboration with the state regulators to ensure such drugs are identified and removed from the market, the sources said.

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Govt approves Rs2584 crore for Small Hydro Power Projects with an capacity of 1500 MW
  • Hormuz traffic plunges sharply, daily vessel crossings drop to 10 from 135 in Feb: S&P Global Energy
  • IRDAI meets stakeholders of healthcare industry,forms 5 Working Groups for addressing critical challenges in health insurance
  • 7 killed in fire after explosion at EV charging point outside house in Indore
  • MACT orders Bajaj Allianz General to pay Rs4.59 crore as compensation to parents of a 35-year-old Italian engineer

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy